REG - Arix Bioscience Plc - Publication of Annual Report & Notice of AGM

Arix BioscienceAnnouncement

12/05/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220512:nRSL9948Ka&default-theme=true

RNS Number : 9948K  Arix Bioscience Plc  12 May 2022

12 May 2022

 

ARIX BIOSCIENCE PLC (the "Company")

Publication of Annual Report and Notice of Annual General Meeting

 

Further to the Company's 2021 Annual Financial Results announcement issued on
5 May 2022, Arix Bioscience Plc, announces that it has today published the
Annual Report and Accounts (the "Annual Report") for the financial year ended
31 December 2021 together with its Notice of 2022 Annual General Meeting (the
"AGM").

 

The Company hereby confirms that its Annual General Meeting will be held on
Tuesday 7 June 2022 at 11:00 (BST) at the offices of Brown Rudnick LLP, 8
Clifford Street, London, W1S 2LQ, United Kingdom.

 

The following documents have today been posted or otherwise made available to
shareholders by the Company:

1.     Form of Proxy

2.     Notice of 2022 Annual General Meeting

3.    Annual Report and Accounts 2021

 

The Form of Proxy is publicly available on the Company's website:

https://arixbioscience.com/investor-relations/document-library
(https://arixbioscience.com/investor-relations/document-library)

The Annual Report and Notice of AGM is also publicly available on the
Company's website:

https://arixbioscience.com/investor-relations/document-library
(https://arixbioscience.com/investor-relations/document-library)

 

Copies of the above documents have been submitted to the UK National Storage
Mechanism. The documents will therefore shortly be available for inspection at
 https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)  and at the
following address:

 

 

Arix Bioscience Plc

Duke Street House,

50 Duke Street,

London,

W1K 6JL,

United Kingdom

 

Enquiries:

Email:     ir@arixbioscience.com (mailto:ir@arixbioscience.com)

LEI:          213800OVT3AHQCXNIX43

 

Registrar and Receiving Agent:  Equiniti Limited - 0371 384 2030 or +44 121
415 7047

Company Secretary: Kin Company Secretarial Limited - +44 20 8819 6486

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOASFLFLSEESEDI